Zobrazeno 1 - 10
of 504
pro vyhledávání: '"Pavón, MA"'
Autor:
Nibu KI; Department of Otolaryngology-Head and Neck Surgery, Kobe University, Graduate School of Medicine, Kobe, Hyogo, Japan., Oridate N; Department of Otolaryngology, Head and Neck Surgery, School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan., Saito Y; Department of Otolaryngology, Head and Neck Surgery, University of Tokyo, Tokyo, Japan., Roset M; IQVIA, Barcelona, Spain., Forés Maresma M; IQVIA, Barcelona, Spain., Cuadras D; IQVIA, Barcelona, Spain., Morais E; MSD France, Puteaux, France., Roberts C; Merck & Co., Inc., Rahway, New Jersey, USA., Chen YT; Merck & Co., Inc., Rahway, New Jersey, USA., Spitzer J; Merck & Co., Inc., Rahway, New Jersey, USA., Sato K; MSD K.K., Tokyo, Japan., Saito I; MSD K.K., Tokyo, Japan., Tazaki I; MSD K.K., Tokyo, Japan., Clavero O; Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, EPIBELL, Barcelona, Spain.; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Schroeder L; German Cancer Research Center (DKFZ), Heidelberg, Germany., Alemany L; Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, EPIBELL, Barcelona, Spain.; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Mehanna H; Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, UK., Mirghani H; Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Hôpital Européen Georges Pompidou, APHP, Université Paris-Cité, Paris, France., Giuliano AR; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Pavón MA; Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, EPIBELL, Barcelona, Spain.; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., Waterboer T; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Cancer science [Cancer Sci] 2024 Aug; Vol. 115 (8), pp. 2808-2818. Date of Electronic Publication: 2024 Jun 07.
Autor:
López-Codony V; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), Barcelona, Spain., de Andrés-Pablo Á; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), Barcelona, Spain., Ferrando-Díez A; Medical Oncology Department, Catalan Institute of Oncology, Germans Trias i Pujol University Hospital (HGTiP), Badalona, Barcelona, Spain., Fernández-Montolí ME; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., López-Querol M; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain., Tous S; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain., Ortega-Expósito C; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., Torrejón-Becerra JC; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., Pérez Y; Department of Gynaecology, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., Ferrer-Artola A; Bellvitge Biomedical Research Institute (IDIBELL), Pharmacy Unit, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat, Barcelona, Spain., Sole-Sedeno JM; Department of Obstetrics and Gynaecology, Hospital del Mar-Mar Health Park, Barcelona, Spain., Grau C; Sexual and Reproductive Health Care Center-ASSIR, Delta del Llobregat, Barcelona, Spain., Rupérez B; Sexual and Reproductive Health Care Center-ASSIR, Delta del Llobregat, Barcelona, Spain., Saumoy M; HIV and STD Unit, Bellvitge University Hospital (HUB), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Sánchez M; HIV and STD Unit, Bellvitge University Hospital (HUB), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Peremiquel-Trillas P; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Programa de Doctorat en Biomedicina, Universitat de Barcelona (UB), Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain., Bruni L; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain., Alemany L; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain., Bosch FX; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.; Faculty of Health Sciences, Open University of Catalonia (UOC), Barcelona, Spain., Pavón MA; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Cancer Epidemiology Research Programme, L'Hospitalet de Llobregat, Barcelona, Spain.; Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Publikováno v:
PloS one [PLoS One] 2024 May 20; Vol. 19 (5), pp. e0304080. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).
Autor:
Giuliano AR; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center and Research Institute, Tampa, Florida., Felsher M; Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Rahway, New Jersey., Waterboer T; German Cancer Research Center (DKFZ), Heidelberg, Germany., Mirghani H; Hôpital Européen Georges-Pompidou, Assistance Publique - Hôpitaux de Paris, Université Paris Cité, Paris, France., Mehanna H; Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, England., Roberts C; Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Rahway, New Jersey., Chen YT; Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Rahway, New Jersey., Lynam M; IQVIA, Barcelona, Spain., Pedrós M; IQVIA, Barcelona, Spain., Sanchez E; IQVIA, Barcelona, Spain., Sirak B; Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center and Research Institute, Tampa, Florida., Surati S; Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Rahway, New Jersey., Alemany L; Unit of Molecular Epidemiology and Genetics (UNIC EMG), Cancer Epidemiology Research Program, Catalan Institute of Oncology, ICO, L'Hospitalet, Barcelona, Spain.; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Spain.; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Morais E; MSD France, Puteaux, France., Pavón MA; Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Spain.; CIBER en Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Laboratory Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, ICO, L'Hospitalet, Barcelona, Spain.
Publikováno v:
JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2023 Sep 01; Vol. 149 (9), pp. 783-795.
Autor:
Ferrando-Díez A; Medical Oncology Department, Catalan Institute of Oncology-Badalona (ICO), Applied Research Group in Oncology (B-ARGO), IGTP, 08916 Badalona., Pavón MA; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain., Cirauqui B; Medical Oncology Department, Catalan Institute of Oncology-Badalona (ICO), Applied Research Group in Oncology (B-ARGO), IGTP, 08916 Badalona., Alemany L; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain., Mesía R; Medical Oncology Department, Catalan Institute of Oncology-Badalona (ICO), Applied Research Group in Oncology (B-ARGO), IGTP, 08916 Badalona.
Publikováno v:
Current opinion in oncology [Curr Opin Oncol] 2023 May 01; Vol. 35 (3), pp. 145-150. Date of Electronic Publication: 2023 Mar 20.
Autor:
Mena M; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Wang X; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Tous S; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Quiros B; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Clavero O; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Alejo M; Pathology Department, Hospital de Vic, 08500 Vic, Spain.; Pathology Department, Hospital General de l'Hopitalet, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Morey F; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Taberna M; Oncology Department, Catalan Institute of Oncology (ICO)-IDIBELL, ONCOBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain., Leon Vintro X; Otorhinolaryngology Department, Hospital Sant Pau, 08026 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain., Lloveras Rubio B; Pathology Department, Hospital del Mar, 08003 Barcelona, Spain., Alos L; Pathology Department, Hospital Clinic, 08036 Barcelona, Spain., Mehanna H; Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham B15 2TT, UK., Quint W; DDL Diagnostic Laboratory, 2288 ER Rijswijk, The Netherlands., Pawlita M; Division of Molecular Diagnostics of Oncogenic Infections, Research Program Infection, Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Tommasino M; Infections and Cancer Biology Group, International Agency for Research on Cancer (IARC), 69372 Lyon, France., Pavón MA; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., Muñoz N; National Cancer Institute, Bogotá 111511, Colombia., De Sanjose S; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.; ISGlobal, 08036 Barcelona, Spain., Bosch FX; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Universitat Oberta de Catalunya, 08035 Barcelona, Spain., Alemany L; Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO)-IDIBELL, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, 28029 Madrid, Spain., On Behalf Of The Ico International Hpv In Head And Neck Cancer Study Group
Publikováno v:
Cancers [Cancers (Basel)] 2022 Aug 04; Vol. 14 (15). Date of Electronic Publication: 2022 Aug 04.
Autor:
Asensio-Puig L; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Alemany L; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain., Pavón MA; Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Publikováno v:
Frontiers in artificial intelligence [Front Artif Intell] 2022 Jun 23; Vol. 5, pp. 851841. Date of Electronic Publication: 2022 Jun 23 (Print Publication: 2022).
Autor:
Porras Pavón, Mª Dolores
Publikováno v:
idUS. Depósito de Investigación de la Universidad de Sevilla
instname
instname
Universidad de Sevilla. Grado en Fundamentos de Arquitectura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c16dbcb084cb7c0ed08f5d649fdd491f
https://idus.us.es/handle/11441/45767
https://idus.us.es/handle/11441/45767
Autor:
Hong Chung1, Jin Bong Choi2, Sooyoun Kim3, Seung-Ju Lee4, Sangrak Bae5 robinbae97@catholic.ac.kr
Publikováno v:
Investigative & Clinical Urology. Nov2024, Vol. 65 Issue 6, p579-586. 8p.
Autor:
Lorenzo-Martín LF; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain., Fernández-Parejo N; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain., Menacho-Márquez M; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Inmunología Clínica y Experimental de Rosario (IDICER, CONICET-UNR). Facultad de Ciencias Médicas Universidad Nacional de Rosario (M.M.-M.) and CellPress editorial office (S.F.), S2000LRJ, Rosario, Argentina., Rodríguez-Fdez S; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain., Robles-Valero J; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain., Zumalave S; Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782, Santiago de Compostela, Spain., Fabbiano S; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Inmunología Clínica y Experimental de Rosario (IDICER, CONICET-UNR). Facultad de Ciencias Médicas Universidad Nacional de Rosario (M.M.-M.) and CellPress editorial office (S.F.), S2000LRJ, Rosario, Argentina., Pascual G; Institute for Research in Biomedicine, 33011, Barcelona, Spain.; The Barcelona Institute of Science and Technology, Barcelona, 33011, Spain., García-Pedrero JM; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain.; Hospital Universitario Central de Asturias, Oviedo University, 33011, Oviedo, Spain., Abad A; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain., García-Macías MC; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain., González N; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain., Lorenzano-Menna P; Laboratory of Molecular Oncology and National University of Quilmes, Buenos Aires, B1876BXD, Argentina.; National Council of Scientific and Technical Research (CONICET), National University of Quilmes, Buenos Aires, B1876BXD, Argentina., Pavón MA; Institut Català d'Oncologia, 08908, L'Hospitalet de Llobregat, Spain.; Centro Biomédica de Investigación en Red de Enfermedades Respiratorias (CIBERESP), 08908, L'Hospitalet de Llobregat, Spain., González-Sarmiento R; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca, 37007, Salamanca, Spain., Segrelles C; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040, Madrid, Spain., Paramio JM; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040, Madrid, Spain., Tubío JMC; Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782, Santiago de Compostela, Spain., Rodrigo JP; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain.; Hospital Universitario Central de Asturias, Oviedo University, 33011, Oviedo, Spain., Benitah SA; Institute for Research in Biomedicine, 33011, Barcelona, Spain.; The Barcelona Institute of Science and Technology, Barcelona, 33011, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), 33011, Barcelona, Spain., Cuadrado M; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain., Bustelo XR; Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain. xbustelo@usal.es.; Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, 37007, Salamanca, Spain. xbustelo@usal.es.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007, Salamanca, Spain. xbustelo@usal.es.
Publikováno v:
Nature communications [Nat Commun] 2020 Sep 22; Vol. 11 (1), pp. 4788. Date of Electronic Publication: 2020 Sep 22.
Autor:
Mena M; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain. mmena@iconcologia.net.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. mmena@iconcologia.net., Frias-Gomez J; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; University of Barcelona, Barcelona, Spain., Taberna M; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Department of Medical Oncology, ICO, L'Hospitalet de Llobregat, Barcelona, Spain.; Program of Molecular Mechanisms and Experimental Therapy in Oncology (ONCOBELL), IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Quirós B; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Marquez S; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Clavero O; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Baena A; Tobacco Control Unit, WHO Collaborating Centre for Tobacco Control, ICO, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Department of E-Health, Faculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain., Lloveras B; Department of Pathology, Hospital del Mar, Barcelona, Spain., Alejo M; Department of Pathology, Hospital General de L'Hospitalet, Barcelona, Spain., León X; Department of Otorhinolaryngology, Hospital de Sant Pau, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain., García J; Department of Otorhinolaryngology, Hospital de Sant Pau, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Instituto de Salud Carlos III, Madrid, Spain., Mesía R; Department of Medical Oncology, ICO, B-ARGO Group, Badalona, Barcelona, Spain., Bermejo O; Department of Plastic Surgery, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain., Bonfill T; Department of Medical Oncology, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain., Aguila A; Department of Otorhinolaryngology, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain., Guix M; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain., Hijano R; Department of Otorhinolaryngology, Hospital del Mar, Barcelona, Spain., Pavón MA; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Torres M; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Tous S; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Clèries R; Pla Director d'Oncologia, ICO, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Dept. Ciències Clíniques, Universitat de Barcelona, Barcelona, Spain., Alemany L; Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain. lalemany@iconcologia.net.; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. lalemany@iconcologia.net.; Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. lalemany@iconcologia.net.
Publikováno v:
Scientific reports [Sci Rep] 2020 Aug 06; Vol. 10 (1), pp. 13219. Date of Electronic Publication: 2020 Aug 06.